SKYE · Skye Bioscience, Inc.
$0.61
-0.01 (-1.45%)
At close · Jul 29
Going-concern doubt
— flagged May 11, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These conditions give rise to substantial doubt as to the Company's ability to continue as a going concern within one year after the date that these financial statements are issued. After considering the plans to alleviate substantial doubt, management has concluded that there is substantial doubt about the Company's ability to continue as a going concern within one year after the date that these financial statements are issued.”View the 10-Q filed May 11, 2026
Market Cap
$21.61M
Shares
35.14M
Fails to deliver — shares from a trade that were not delivered to the buyer by the settlement date — published by the SEC twice a month. Persistent fails can reflect settlement problems or naked short selling.
Fails to Deliver History
| Settlement Date | Quantity | Price | Value |
|---|---|---|---|
| 2026-06-30 | 25,101 | $0.67 | $16,818 |
| 2026-06-26 | 1,112 | $0.71 | $790 |
| 2026-06-25 | 9,418 | $0.68 | $6,404 |
| 2026-06-24 | 8,254 | $0.70 | $5,778 |
| 2026-06-22 | 2,719 | $0.71 | $1,930 |
| 2026-06-18 | 53 | $0.71 | $38 |
| 2026-06-15 | 2,975 | $0.79 | $2,350 |
| 2026-06-11 | 22,305 | $0.78 | $17,398 |
| 2026-06-10 | 15,340 | $0.75 | $11,505 |
| 2026-06-09 | 19,568 | $0.77 | $15,067 |
| 2026-06-08 | 18,643 | $0.73 | $13,609 |
| 2026-06-05 | 13,585 | $0.77 | $10,460 |
| 2026-06-03 | 94,455 | $0.71 | $67,063 |
| 2026-06-02 | 94,442 | $0.76 | $71,776 |
| 2026-06-01 | 122,051 | $0.78 | $95,200 |
| 2026-05-20 | 3,579 | $0.73 | $2,613 |
| 2026-05-19 | 5,064 | $0.78 | $3,950 |
| 2026-05-14 | 3,699 | $0.82 | $3,033 |
| 2026-05-12 | 99 | $0.88 | $87 |
| 2026-05-11 | 7,400 | $0.86 | $6,364 |
Showing 1–20 of 20 settlements